The coming Democrat-controlled House of Representatives could dramatically alter the path of U.S. health policy; now is the time to try Inside Health Policy. .

Sign up for 30 days of no-obligation access for all the essential news during this critical time -- you'll be able to choose one of our online services as part of your trial: Inside CMS, FDA Week, Health Exchange Alert or Inside Drug Pricing.


Top Story

GOP Weighs Severing Mandate From ACA If Court Deems It Unconstitutional

Republican senators who introduced a bill to protect the Affordable Care Act’s coverage of preexisting conditions are waiting on a ruling in the controversial ACA case in Texas before charting their next steps, which could include adding a severability clause to the health law.

Latest News

After months of deliberation and public meetings, FDA and the U.S. Department of Agriculture officially announced they will share the responsibility for regulating cell-based meats, where food resembling meat, poultry and seafood is produced using small amounts of cells from the animal that the food product is supposed to resemble.

Incoming Senate Finance Committee chairman Charles Grassley (R-IA) and Senate Democratic Whip Dick Durbin (D-IL) on Friday asked the Trump administration to put in place by year’s end its proposal to require drug manufacturers disclose list prices in direct-to-consumer advertising, and they also called on HHS and CMS to adopt additional drug-price disclosure measures.

The American Medical Association is recommending processes and parameters for prior authorization, which the doctor group says are aimed at improving the experience of Medicare and Medicaid patients while making things easier for doctors.

The White House budget office on Tuesday (Nov. 13) began reviewing HHS’ request for feedback on ways to revamp the Health Insurance Portability and Accountability Act to boost efforts to coordinate care.

In a highly anticipated move, FDA Commissioner Scott Gottlieb on Thursday (Nov. 15) announced a number of new tobacco-related initiatives the agency is undertaking, including revisiting the deeming rule compliance policy to restrict access to flavored electronic nicotine delivery systems (ENDS).

In a slate of tobacco-related policy proposals issued Thursday (Nov. 15), FDA Commissioner Scott Gottlieb said the agency will move forward with a proposed ban on menthol in combustible tobacco products, including cigars and cigarettes, as well as a ban on all flavored cigars.

HHS Secretary Alex Azar doubled down on the Trump administration’s controversial plan to lower Medicare Part B drug costs by relying on international reference prices in a speech to the Commonwealth Fund International Symposium on Health Care Wednesday.

The White House Office of Management and Budget is reviewing a proposed rule aimed at reducing the administrative burden on long-term care facilities in Medicare and Medicaid.

FDA drug center director Janet Woodcock said rising drug prices are changing the nature of debate surrounding the agency’s drug development requirements.